New York Life Investment Management’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,833
Closed -$369K 992
2024
Q1
$369K Sell
3,833
-201
-5% -$17.3K ﹤0.01% 997
2023
Q4
$336K Sell
4,034
-93
-2% -$6.95K ﹤0.01% 1146
2023
Q3
$313K Sell
4,127
-651
-14% -$52.9K ﹤0.01% 1116
2023
Q2
$377K Sell
4,778
-833
-15% -$70.2K ﹤0.01% 1086
2023
Q1
$484K Sell
5,611
-360
-6% -$32.1K 0.01% 819
2022
Q4
$483K Buy
5,971
+675
+13% +$57.3K 0.01% 953
2022
Q3
$435K Buy
5,296
+389
+8% +$38.3K 0.01% 859
2022
Q2
$538K Buy
+4,907
New +$486K 0.01% 692

Other funds holding DORM

New York Life Investment Management's DORM Position: Q2 2024 in Review

New York Life Investment Management sold out of Dorman Products (DORM) in Q2 2024, closing a stake of 3,833 shares — an estimated $369K sold.

New York Life Investment Management first reported a position in DORM in Q2 2022 and held it in 8 quarters. The position peaked at $538K in Q2 2022. 264 funds tracked by Wall St. Rank hold DORM as of Q2 2024.

  • New York Life Investment Management reported no remaining Dorman Products position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 3,833 Dorman Products shares in Q2 2024, an estimated $369K.
  • New York Life Investment Management first reported a position in Dorman Products in Q2 2022 and held it in 8 quarters.
  • New York Life Investment Management's Dorman Products position peaked at $538K in Q2 2022.
  • 264 funds tracked by Wall St. Rank held Dorman Products as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.